In this webinar, our very own Glaucoma specialist, Christine Funke, MD, shares evidence supporting early glaucoma intervention. Dr. Funke, joined by Dr. Manjool Shah of NYU Langone Health and Dr. Inder Paul Singh of The Eye Centers of Racine and Kenosha, discusses the benefits of early intervention glaucoma treatment with SLT (Selective Laser Trabeculoplasty).
This discussion highlights how advancements like SLT are reshaping glaucoma treatment, offering patients better outcomes than those treated with eye drops and a 5-minute procedure that treats the cause and provides peace of mind.
Dr. Funke’s advocacy for early treatment underscores the critical role of SLT in preserving vision and preventing blindness.
“Because glaucoma is a disease that someone may have but not know until their vision is severely affected, I am passionate about how to catch it and treat it early. Interventional glaucoma is imperative because the earlier we treat glaucoma, the better the long-term outcome for a patient’s vision,” – Dr. Christine Funke, glaucoma specialist at Barnet Dulaney Perkins Eye Center.